ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,182 | +31.8% | 412 | +49.3% | 0.00% | 0.0% |
| Q2 2023 | $8,484 | -50.3% | 276 | -41.8% | 0.00% | -50.0% |
| Q1 2023 | $17,078 | +1778.8% | 474 | +1960.9% | 0.00% | – |
| Q4 2022 | $909 | – | 23 | +130.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 10 | -94.4% | 0.00% | -100.0% |
| Q2 2022 | $8,000 | +700.0% | 179 | +616.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 418 | $11,742 | 0.00% |
| Versant Capital Management, Inc | 20 | $562 | 0.00% |